Erin Burkhart Biomarin Pharmaceutical Inc (BMRN) insider trading activity

Erin Burkhart is GVP, Chief Accounting Officer of BIOMARIN PHARMACEUTICAL INC. Currently has a direct ownership of 14,173 shares of BMRN, which is worth approximately $827,278. The most recent transaction as insider was on May 20, 2025, when has been sold 1,786 shares (Common Stock) at a price of $59.31 per share, resulting in proceeds of $105,927. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.2K

16.41% 3M change

6.53% 12M change

Total Value Held $827,278

Erin Burkhart Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 20 2025	SELL Open market or private sale	$105,927 $59.31 p/Share	1,786 Reduced 11.19%	14,173 Common Stock
May 19 2025	SELL Payment of exercise price or tax liability	$59,032 $59.27 p/Share	996 Reduced 5.87%	15,959 Common Stock
Mar 19 2025	SELL Open market or private sale	$92,618 $71.52 p/Share	1,295 Reduced 7.1%	16,955 Common Stock
Mar 17 2025	BUY Grant, award, or other acquisition	-	5,970 Added 24.65%	18,252 Common Stock
Mar 14 2025	SELL Payment of exercise price or tax liability	$57,149 $69.44 p/Share	823 Reduced 6.28%	12,282 Common Stock
Feb 24 2025	SELL Open market or private sale	$91,902 $68.38 p/Share	1,344 Reduced 9.3%	13,105 Common Stock
Aug 13 2024	SELL Open market or private sale	$64,260 $90.0 p/Share	714 Reduced 4.71%	14,449 Common Stock
May 17 2024	SELL Payment of exercise price or tax liability	$76,431 $76.97 p/Share	993 Reduced 6.15%	15,163 Common Stock
Apr 10 2024	SELL Open market or private sale	$205,740 $90.0 p/Share	2,286 Reduced 12.4%	16,156 Common Stock
Mar 18 2024	SELL Payment of exercise price or tax liability	$31,199 $83.87 p/Share	372 Reduced 1.98%	18,442 Common Stock
Mar 15 2024	BUY Grant, award, or other acquisition	-	4,720 Added 20.06%	18,814 Common Stock
May 16 2023	SELL Payment of exercise price or tax liability	$73,247 $92.02 p/Share	796 Reduced 5.35%	14,094 Common Stock
Mar 15 2023	BUY Grant, award, or other acquisition	-	3,760 Added 20.16%	14,890 Common Stock
May 16 2022	BUY Grant, award, or other acquisition	-	11,130 Added 50.0%	11,130 Common Stock

Erin Burkhart

GVP, Chief Accounting Officer

San Rafael, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMRN shares.

Notify only if

Value

Insider Trading

Get notified when an Biomarin Pharmaceutical Inc insider buys or sells BMRN shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOMARIN PHARMACEUTICAL INC

Track Activities on BMRN

Account